Mary J. Gleeson

Mary J. Gleeson

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

The diagnosis and management of primary mediastinal B-cell lymphoma: A British Society for Haematology guideline.

The diagnosis and management of primary mediastinal B-cell lymphoma: A British Society for Haematology guideline.

Journal: British journal of haematology

Published: April 03, 2026

Glofitamab in refractory Burkitt lymphoma-type post-transplant lymphoproliferative disorder.

Glofitamab in refractory Burkitt lymphoma-type post-transplant lymphoproliferative disorder.

Journal: British journal of haematology

Published: February 09, 2026

Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencing.

Glofitamab and epcoritamab for large B cell lymphoma: a real-world retrospective UK analysis of efficacy, tolerability, and impact of treatment sequencing.

Journal: Haematologica

Published: January 21, 2026

The role of PET/CT in peripheral T-cell lymphoma: Results from the PET/CT substudy of the UK NCRI phase 2 CHEMO-T trial.

The role of PET/CT in peripheral T-cell lymphoma: Results from the PET/CT substudy of the UK NCRI phase 2 CHEMO-T trial.

Journal: British journal of haematology

Published: February 23, 2025

Nodal Peripheral T-Cell Lymphoma: Therapeutic Challenges and Future Perspectives.

Nodal Peripheral T-Cell Lymphoma: Therapeutic Challenges and Future Perspectives.

Journal: Cancers

Published: February 17, 2025

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience.

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience.

Journal: Blood advances

Published: July 26, 2023

Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital.

Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital.

Journal: Clinical lymphoma, myeloma & leukemia

Published: July 18, 2023

Beyond CHOP: optimising frontline therapy in peripheral T-cell lymphoma.

Beyond CHOP: optimising frontline therapy in peripheral T-cell lymphoma.

Journal: Annals of palliative medicine

Published: May 15, 2022

Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance.

Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance.

Journal: Haematologica

Published: May 09, 2022

Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma.

Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 04, 2020

ABVD and BEACOPP regimens' effects on fertility in young males with Hodgkin lymphoma.

ABVD and BEACOPP regimens' effects on fertility in young males with Hodgkin lymphoma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 21, 2020

Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London.

Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London.

Journal: Frontiers in oncology

Published: June 01, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026